S-095035

N/A

Report date: 2026/03/27 20:01:50

Base Information

Drug NameS-095035
Drug Alias NameMAT2A Inhibitor therapy (Servier Bio-Innovation)S095035S-095035S-95035
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionS-adenosylmethionine synthase isoform type-2 inhibitors
TargetsS-adenosylmethionine synthase isoform type-2
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesItalyDenmark +[9
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaIND
Originator CompaniesServier Bio-Innovation LLC
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A